1 results match your criteria: "Department of General Surgery and Institute of Metabolic and Bariatric Surgery[Affiliation]"
Impact of selective serotonin reuptake inhibitors on weight loss after vertical sleeve gastrectomy.
Surg Obes Relat Dis
August 2024
Department of General Surgery and Institute of Metabolic and Bariatric Surgery, Abington Jefferson Health, Abington, Pennsylvania.
Background: Mental health disorders, such as depression, are prominent within the bariatric population, with antidepressants ranking among the most frequently prescribed medications.
Objectives: Our surgery aimed to investigate selective serotonin reuptake inhibitor (SSRI) effects on weight loss in patients undergoing vertical sleeve gastrectomy (VSG).
Setting: University affiliated Community Hospital, United States.